Extension Study, Pilot, Compassionate Use of Azacitidine 300 mg Film Coated Tablets for Acute Myeloid Leukaemia (AML) Patients
Clinical trial NCT06572982 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06572982
- Sponsor
- Hikma Pharmaceuticals LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-29
- Primary completion
- 2026-05-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.